AU Stock MarketDetailed Quotes
NEU Neuren Pharmaceuticals Ltd
- 12.690
- +0.220+1.76%
20min DelayNot Open Dec 2 16:00 AET
1.65BMarket Cap10.56P/E (Static)
12.840High12.550Low465.42KVolume12.570Open12.470Pre Close5.91MTurnover25.95052wk High0.42%Turnover Ratio130.07MShares12.02052wk Low0.944EPS TTM1.41BFloat Cap65.000Historical High10.56P/E (Static)110.82MShs Float0.060Historical Low1.202EPS LYR2.33%Amplitude--Dividend TTM4.90P/B1Lot Size--Div YieldTTM
About Neuren Pharmaceuticals Ltd Company
Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.
Company Profile
SymbolNEU
Company NameNeuren Pharmaceuticals Ltd
Founded2004
MarketASX
Employees11
Fiscal Year Ends12-31
Address697 Burke Road Suite 201
CityMelbourne
CountryAustralia
Zip Code3124
Phone+61 390920480
Websitehttps://www.neurenpharma.com
Share RegistryLINK MARKET SERVICES LIMITED
Tower 4, 727 Collins Street, DOCKLANDS, VIC, AUSTRALIA, 3008
1300 554 474
Company Executives
- Name
- Position
- Salary
- Jonathan Pilcher
- Director, Chief Executive Officer and Managing Director
- --
- Patrick Donald Davies, M.B.A.
- Non-Executive Chairman of the Board
- --
- Dr. Jenny Harry
- Independent Director
- --
- Dianne Angus
- Independent Director
- --
- Joe Basile
- Independent Director
- --
- Dr. Trevor Scott
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data